Company
Every investor coverage indicates participated in a round Clarity Pharmaceutical raised.
Investors whose own portfolio pages list Clarity Pharmaceutical, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Boson Ventures | its portfolio page ↗ |
The transaction that ended Clarity Pharmaceutical's run as a startup, per published coverage. It closes the funding history too, where it is the ladder's last rung.
| Bought by | Kind | Announced | Price | Sources |
|---|---|---|---|---|
| - | IPO | 2021 | $358m | Business News Australia, Techboard |
Companies Clarity Pharmaceutical acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Clarity Pharmaceutical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney Angels' third sidecar fund raised $3.5 million on VentureCrowd in a week to back early-stage startups, while the article recalls past fund wins including Clarity Pharmaceuticals, Instaclustr and Aurtra.
Starpharma, two universities, Telix, Clarity and CSIRO launch an ARC-backed radiopharmaceutical research hub with a government grant and industry funding.
Techboard announces the 2022 Australian Angel Awards winners, honouring Tim Hirst as Angel of the Year and Brisbane Angels for its Clipchamp exit, while recalling past raises and exits including Clarity Pharmaceuticals and Instaclustr.